Crestor rosuvastatin: Phase IIIb started

AZN began the open-label, Argentinean Phase IIIb GRAVITY trial in 800 patients. The study will compare 10 or 20 mg Crestor plus 10mg of ezetimibe to Vytorin simvastatin/ezetimibe from Schering-Ploug...